Login to Your Account



Cytos Signs $139M Deal with Pfizer for Immunodrug Vaccines

By Trista Morrison


Monday, August 18, 2008
As three of its own Immunodrug vaccine candidates advance through clinical trials, Cytos Biotechnology AG signed a CHF150 (US$139 million) technology deal with Pfizer Inc.'s vaccine unit. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription